for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover The Tan Sheet
  [0 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [16 journals]
  • Judge Rejects Prior Restraint For Tylenol Ads Ahead
           Of 'Bellwether' Trial
    • Abstract: J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
      PubDate: Fri, 24 Jun 2016 00:00:18 -040
       
  • Need For Better Research Grows With Supplements' Popularity – NCCIH
    • Abstract: Continued research on non-vitamin and -mineral products' safety is necessary, says National Center for Complementary and Integrative Health Director Josephine Briggs, and improved studies on their effects on users' health are a scientific priority in the center's strategic plan.
      PubDate: Thu, 23 Jun 2016 00:00:03 -040
       
  • FTC Diagnosis For 'Doctor Trusted' Certificates: 'Meaningless'
    • Abstract: "Doctor Trusted" certificates were based on two doctors "superficially" reviewing products online without actually evaluating the products or determining whether advertising claims were supported.
      PubDate: Wed, 22 Jun 2016 00:00:02 -040
       
  • Chewable Tablet Adverse Events, Manufacturing Slips Prompt Guidance
    • Abstract: Chewable tablet manufacturers are overlooking quality attributes, leading to adverse events, according to an FDA draft guidance. The agency recommends firms establish hardness, dissolution and disintegration of products early in manufacturing.
      PubDate: Tue, 21 Jun 2016 00:05:01 -040
       
  • Perrigo Out From Under VMS Weight As IVC Lifts Private Label Profile
    • Abstract: The cash deal for Perrigo's vitamins, minerals and supplements business will make International Vitamin Corporation the largest US private label nutritional product manufacturer and better position Perrigo to either continue on its own or as an even more attractive takeover target.
      PubDate: Tue, 21 Jun 2016 00:00:04 -040
       
  • Industry Roundup: UK Ad Claims, Doctor's Best Sold, Delaware DXM Bill
    • Abstract: UK firm responsible for distributors' social media claims; Juice Garden blooms UK bogus claims; and more news in brief.
      PubDate: Mon, 20 Jun 2016 00:05:03 -040
       
  • Rulemaking Process Flawed, But Making Monograph Rules Still Needs Funding
    • Abstract: The monograph program was "instituted really many, many decades ago. We've been trying to implement it since," says CDER Director Janet Woodcock. "We haven't had a much bigger pie to play with, so that's been one constraint that we've had to deal with," says center budget chief Donal Parks.
      PubDate: Mon, 20 Jun 2016 00:04:00 -040
       
  • Patent Settlements Stir Supreme Court Interest During Slow Term For Pharma
           Cases
    • Abstract: High court seeks Solicitor General's view on whether patent settlements blocking authorized generics are anticompetitive; court denies GSK petition challenging payer claims in Avandia litigation.
      PubDate: Mon, 20 Jun 2016 00:02:09 -040
       
  • FDA Prescription Drug User Fee Program Could Go OIG Scrutiny
    • Abstract: In addition to user fees, upcoming FDA reviews will focus on oversight of post-marketing requirements and information exchange in the drug supply chain.
      PubDate: Mon, 20 Jun 2016 00:01:59 -040
       
  • Executive Decisions Roundup: CHPA And AHPA Boards, Vitamin Shoppe COO
    • Abstract: Vitamin Shoppe expands management; Vitamin Way spokeswoman teed up; Herbalife sponsors LA Galaxy player; and more news in brief.
      PubDate: Mon, 20 Jun 2016 00:01:52 -040
       
  • Consumer Health New Products Roundup: MegaFood, Kirkman, Bausch + Lomb
    • Abstract: Supplement for swallowing disorders; single-serve protein pouches; more chocolate superfood; and more news in brief.
      PubDate: Mon, 20 Jun 2016 00:01:40 -040
       
  • Prosecutions Send Spiked Consumer Health Product Marketers To Prison
    • Abstract: The convictions in federal district courts ought to interest supplement industry stakeholders long calling for DoJ and FDA to prosecute criminal charges stemming from investigations of spiked supplements, but likely will also prompt calls for authorities to drill down with charges against the sources of the products.
      PubDate: Mon, 20 Jun 2016 00:01:11 -040
       
  • Weekly Trademark Review June 14, 2016
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent & Trademark Office.
      PubDate: Mon, 20 Jun 2016 00:00:33 -040
       
  • Supplement Industry Questions Prop 65 Warning Proposal's Clarity On
           Placement
    • Abstract: California's latest modifications to Prop 65 “clear and reasonable” warnings do not state that short-form, on-product warnings are allowed for food and supplement products, but the state told stakeholders it will allow food products to carry the warnings, says the Council for Responsible Nutrition.
      PubDate: Mon, 20 Jun 2016 00:00:18 -040
       
  • Colgate Max White 'Much Whiter' Claim In UK Blurs
           'Instant' Of Effect
    • Abstract: Colgate-Palmolive UK is advised to discontinue a “much whiter” claim for Colgate Max White One Optic toothpaste, but three other claims it made were substantiated, the UK Advertising Standards Authority says. The complaints were submitted by Crest oral care product marketer Procter & Gamble UK.
      PubDate: Fri, 17 Jun 2016 00:00:01 -040
       
  • CDER Asked To Shed More Light On Potential Monograph User Fees
    • Abstract: While Director Janet Woodcock and other CDER officials explain the center's reasons for proposing a monograph program user fee, some stakeholders suggest the agency explain more about how the program would work.
      PubDate: Thu, 16 Jun 2016 00:00:05 -040
       
  • With Zzzquil Efficacy Tests, P&G Highlights
           OTC Sleep Aid Indication
    • Abstract: Sleep researchers recognize many consumers look at Rx sleep disturbance treatments and OTC sleep aids as the same type of products. Still, "people are looking for options that are effective and non-habit-forming and help them get to sleep quickly," says P&G researcher Andrew Carr.
      PubDate: Wed, 15 Jun 2016 00:00:04 -040
       
  • FDA Warns Another 'Stem Cell' Skin Care Marketer On Drug Claims
    • Abstract: Stem cell-related claims on cosmetics may capture consumers' imagination, but they are grabbing FDA's attention as well. Hollywood Skincare International, which markets its DermaSet Stem Cell 3D Renewal cream online, is the latest player in this game to receive a warning letter from the agency.
      PubDate: Tue, 14 Jun 2016 00:45:01 -040
       
  • OTC Monograph User Fees Inspire Wary Support From Industry
    • Abstract: Executives from OTC drug manufacturers list numerous doubts about the equity and effectiveness of a potential program that would impose user fees on firms that make or market monograph drugs, the vast majority of nonprescription pharmaceutical products.
      PubDate: Mon, 13 Jun 2016 00:10:00 -040
       
  • Fraudulent Zika Claims Are CDER's Latest Extermination Target
    • Abstract: CDER is on the lookout for companies seeking to capitalize off the Zika health crisis with fraudulent claims about their products’ ability to treat or prevent the disease, says Brad Price, acting director of the Division of Nonprescription Drugs and Health Fraud, Office of Compliance.
      PubDate: Mon, 13 Jun 2016 00:05:00 -040
       
  • Industry Roundup: Gaia Herbs Grows, Recalls, Warnings
    • Abstract: Power House Energy Drinks investment; testing lapse prompts Pharmavite recall; Sweden's Probi acquires US probiotics firm; and more news in brief.
      PubDate: Mon, 13 Jun 2016 00:01:18 -040
       
  • 'Real Challenge' To Improve OTC Monograph Program Without User Fees
           – FDA
    • Abstract: FDA looks at the potential benefits and detriments from establishing user fees for the monograph program, opening a docket for comments in addition to conducting the public meeting, as it also considers comments to a docket launched in February 2014 on overhauling the OTC monograph process.
      PubDate: Fri, 10 Jun 2016 00:00:02 -040
       
  • All Economies Are Local In CRN Analysis Of Supplement Industry Impact
    • Abstract: Economic impact data available online complement CRN's surveys on consumers' use of supplements that showed the industry's contribution to public health. For answering questions about supplement firms' impact on the economy, "now we have that tool in our tool box as well," says CRN chief Steve Mister.
      PubDate: Thu, 09 Jun 2016 00:05:00 -040
       
  • Radiation-Protection Supplement Claims Fizzle In NAD Review
    • Abstract: Advanced Nutrition Innovations discontinues claims that its Iondefender supplement could protect against radiation, even in nuclear disaster zones. The firm argued its proprietary active ingredient IsoproutPlex elevated levels of superoxide dismutase antioxidant and help inactivate "reactive oxygen species."
      PubDate: Thu, 09 Jun 2016 00:00:05 -040
       
  • Infirst Extends Mylanta Brand With Nighttime Product,
           Chewable Tablets
    • Abstract: Infirst changes the Mylanta Maximum Strength lemon-mint liquid with a "smoother, creamier formulation," adds a vanilla caramel-flavored version and add another liquid product, Mylanta Tonight featuring a honey chamomile flavor. Also new are Mylanta Gas Minis chewable anti-gas tablets.
      PubDate: Wed, 08 Jun 2016 00:05:00 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.92.175.80
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015